14.29 USD
+0.02 (+0.14%)
At close: Jan 30, 2026
14.2411 USD
-0.05 (-0.34%)
After Hours: 1/30/2026, 8:00:00 PM
ChartMill assigns a Buy % Consensus number of 77% to FOLD. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 16.03. This target is 12.17% above the current price.
- FOLD was analyzed by 14 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about FOLD.
- In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
- FOLD was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-22 | Jefferies | Downgrade | Buy -> Hold |
| 2025-12-29 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-12-22 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-12-19 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2025-12-19 | Needham | Downgrade | Buy -> Hold |
| 2025-12-17 | Citigroup | Initiate | Buy |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-05 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-09-18 | Needham | Upgrade | Hold -> Buy |
| 2025-07-17 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-20 | Needham | Reiterate | Hold -> Hold |
| 2025-02-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-13 | Needham | Reiterate | Hold -> Hold |
| 2024-12-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-11-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-07 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-11-07 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Hold |
| 2024-10-17 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | Jefferies | Initiate | Buy |
| 2024-08-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-09 | Needham | Reiterate | Hold |
| 2024-05-30 | Wells Fargo | Initiate | Overweight |
| 2024-05-14 | Guggenheim | Upgrade | Neutral -> Buy |
| 2024-05-10 | UBS | Maintains | Buy -> Buy |
AMICUS THERAPEUTICS INC / FOLD FAQ
Can you provide the average price target for AMICUS THERAPEUTICS INC stock?
14 analysts have analysed FOLD and the average price target is 16.03 USD. This implies a price increase of 12.17% is expected in the next year compared to the current price of 14.29.
Can you provide the consensus rating for AMICUS THERAPEUTICS INC stock?
The consensus rating for AMICUS THERAPEUTICS INC (FOLD) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for FOLD stock?
The number of analysts covering AMICUS THERAPEUTICS INC (FOLD) is 14.